The identity of human tissue-emigrant CD8 <sup>+</sup> T cells
Marcus Buggert(Karolinska University Hospital), Michael R. Betts(University of Pennsylvania), Afam A. Okoye(Oregon National Primate Research Center), Irene Bukh Brody(University of Pennsylvania), Niklas K. Björkström(Karolinska University Hospital), Ernesto Sparrelid(Karolinska University Hospital), Daniel C. Douek(Institut de Recherche Vaccinale), Terri M. Laufer(Philadelphia VA Medical Center), Sian Llewellyn‐Lacey(University College London Hospitals NHS Foundation Trust), Andrew D. Wells(Children's Hospital of Philadelphia), André Perez‐Potti(University College Dublin), Jack P. Antel(Montreal Neurological Institute and Hospital), Martin A. Ivarsson(Karolinska University Hospital), Laura A. Vella(Children's Hospital of Philadelphia), Maxim Itkin(Hospital of the University of Pennsylvania), E. John Wherry(Parker Institute for Cancer Immunotherapy), Emma Gostick(University Hospital of Wales), Vincent H. Wu(The Wistar Institute), Ian Frank(Norwegian Womens Public Health Association), Takuya Sekine(Karolinska Institutet), Amy Ransier(National Institutes of Health), Yoav Dori(Institute of Cardiology), Alberto Sada Japp(University of Pennsylvania), Amit Bar‐Or(University of Pennsylvania), David H. Canaday(Case Western Reserve University), Colby R. Maldini(Beam Therapeutics (United States)), Ali Naji(University of Pennsylvania), Leticia Kuri-Cervantes(University of Pennsylvania), Louis J. Picker(Oregon National Primate Research Center), Sasikanth Manne(Translational Therapeutics (United States)), Laura Hertwig(Karolinska University Hospital), Samuel Darko, David A. Price(University Hospital of Wales), Golnaz Vahedi(University of Pennsylvania), Matthew E. Johnson(Children's Hospital of Philadelphia), Son Nguyen(Broad Institute)
Cited by 5
Related Papers
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k